Bayer Consolidates US Glyphosate Business
Analysis based on 13 articles · First reported Jul 01, 2026 · Last updated Jul 01, 2026
The consolidation of Bayer Group's U.S. glyphosate business into Ruveon LLC is expected to optimize operations and enhance focus, potentially leading to improved profitability for Bayer. Ruveon's specialized approach in the commodity-based market could increase competition and efficiency within the U.S. agriculture industry.
Bayer Group announced the consolidation of its U.S. glyphosate business into a new entity, Ruveon LLC, based in St. Louis, Missouri. This move is part of Bayer Group's Crop Science division's Five-Year Framework, aimed at driving growth, resilience, and profitability. Ruveon will be solely responsible for all aspects of the U.S. glyphosate business, including pricing, go-to-market strategies, production, and logistics. The new company is expected to be more agile in the competitive commodity market and will continue to supply the U.S. agriculture industry with glyphosate products. Alfonso Alba Ordóñez has been appointed CEO and Steve Knodle as EVP, Head of Commercial Business for Ruveon.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard